Gene · 4012
Papers1,729
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,729
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The intracellular helical bundle of human glucose transporter GLUT4 is important for complex formation with ASPL. | FEBS Open Bio | 2023 | 37731227 | PubTator, text mining | PubMed |
| Maternal PlGF and umbilical Dopplers predict pregnancy outcomes at diagnosis of early-onset fetal growth restriction. | J Clin Invest | 2023 | 37712421 | PubTator, text mining | PubMed |
| Retracted: Beta-Sitosterol Facilitates GLUT4 Vesicle Fusion on the Plasma Membrane via the Activation of Rab/IRAP/Munc 18 Signaling Pathways in Diabetic Gastrocnemius Muscle of Adult Male Rats. | Bioinorg Chem Appl | 2023 | 37664222 | PubTator, text mining | PubMed |
| TEMM: A Curated Data Resource for Transposon Element-Based Molecular Markers in Plants. | Methods Mol Biol | 2023 | 37646936 | PubTator, text mining | PubMed |
| Spatially Resolved Transcriptomics Technology Facilitates Cancer Research. | Adv Sci (Weinh) | 2023 | 37632718 | PubTator, text mining | PubMed |
| Angiotensin Regulation of Vascular Homeostasis: Exploring the Role of ROS and RAS Blockers. | Int J Mol Sci | 2023 | 37569484 | PubTator, text mining | PubMed |
| The association between maternal body mass index and serial plasma oxytocin levels during labor. | PLoS One | 2023 | 37566578 | PubTator, text mining | PubMed |
| Osmotic demyelination syndrome with transient diabetes insipidus in postpartum female: a case report. | Ann Med Surg (Lond) | 2023 | 37554876 | PubTator, text mining | PubMed |
| Exploring the role of ex vivo metabolism on blood and plasma measurements of oxytocin among women in the third stage of labour: A post hoc study. | Br J Clin Pharmacol | 2023 | 37522415 | PubTator, text mining | PubMed |
| Rational engineering of an improved adenosine deaminase 2 enzyme for weaponizing T-cell therapies. | Immunooncol Technol | 2023 | 37519414 | PubTator, text mining | PubMed |
| Concurrent Aerobic and Strength Training with Caloric Restriction Reduces Insulin Resistance in Obese Premenopausal Women: A Randomized Controlled Trial. | Medicina (Kaunas) | 2023 | 37512005 | PubTator, text mining | PubMed |
| Pathomechanisms of Prenatally Programmed Adult Diseases. | Antioxidants (Basel) | 2023 | 37507894 | PubTator, text mining | PubMed |
| Immunopeptidome profiling of human coronavirus OC43-infected cells identifies CD4 T-cell epitopes specific to seasonal coronaviruses or cross-reactive with SARS-CoV-2. | PLoS Pathog | 2023 | 37498934 | PubTator, text mining | PubMed |
| Hypoxia-associated genes predicting future risk of myocardial infarction: a GEO database-based study. | Front Cardiovasc Med | 2023 | 37465452 | PubTator, text mining | PubMed |
| The Role of Oxytocin in Early-Life-Stress-Related Neuropsychiatric Disorders. | Int J Mol Sci | 2023 | 37445607 | PubTator, text mining | PubMed |
| Structure of puromycin-sensitive aminopeptidase and polyglutamine binding. | PLoS One | 2023 | 37440518 | PubTator, text mining | PubMed |
| The aminopeptidase LAP3 suppression accelerates myogenic differentiation via the AKT-TFE3 pathway in C2C12 myoblasts. | J Cell Physiol | 2023 | 37435895 | PubTator, text mining | PubMed |
| Sex differences in the renin-angiotensin-aldosterone system and its roles in hypertension, cardiovascular, and kidney diseases. | Front Cardiovasc Med | 2023 | 37404743 | PubTator, text mining | PubMed |
| Identification of membrane proteins regulated by ADAM15 by SUSPECS proteomics. | Front Mol Biosci | 2023 | 37388246 | PubTator, text mining | PubMed |
| Network-Based Prediction of Side Effects of Repurposed Antihypertensive Sartans against COVID-19 via Proteome and Drug-Target Interactomes. | Proteomes | 2023 | 37368467 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4012/papers?page=5